Skip to content
value.today

Gilead Sciences, Inc. vs Pfizer Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Gilead Sciences, Inc. is the larger company by market value: $193.5 B against $170.7 B for Pfizer Inc., 1.1 times as much (market caps of Oct 26, 2026 for Gilead Sciences, Inc. and Oct 30, 2026 for Pfizer Inc.).
  • Pfizer Inc. had more revenue: $62.6 B against $29.4 B for Gilead Sciences, Inc., both in the year to December 2025.
  • Gilead Sciences, Inc. earned more: net income of $8.5 B against $7.8 B for Pfizer Inc.
  • Gilead Sciences, Inc. keeps more of each dollar of sales: a net margin of 28.9% against 12.4% for Pfizer Inc.
  • Pfizer Inc. employs more people: 75,000 against 17,000 at Gilead Sciences, Inc. Each employee brings in about $1,731,941 of revenue at Gilead Sciences, Inc. and $834,387 at Pfizer Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0581171752342020202120222023202420252026Gilead Sciences, Inc. 234Pfizer Inc. 79

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$25B$51B$76B$101B201720182019202020212022202320242025Gilead Sciences, Inc. $29BPfizer Inc. $63B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureGilead Sciences, Inc.
GILD · #104 in the world
Pfizer Inc.
PFE · #127 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19871849
Size
Market cap$193.5 B$170.7 B
Revenue$29.4 B$62.6 B
Net income$8.5 B▲ best$7.8 B
Employees17,00075,000
Valuation
P/E ratio—42.3×
Price to sales6.3×2.7×
Price to book8.5×2.0×
Free cash flow yield4.9%5.3%▲ best
Profitability
Gross margin—74.3%
Net margin—12.4%
Return on equity—8.9%
Growth
Revenue growth—-1.6%
Revenue growth, 3 years a year—-14.8%
Earnings per share growth—-3.5%
Financial strength
Debt to equity—0.7×
Cash
Free cash flow margin—14.5%
Strength scores
Piotroski F-score—5 of 9
Altman Z-score zone——
Data as ofMarket cap Oct 2026Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Gilead Sciences, Inc. or Pfizer Inc.?

Gilead Sciences, Inc. is the larger company by market value: $193.5 B against $170.7 B for Pfizer Inc., 1.1 times as much (market caps of Oct 26, 2026 for Gilead Sciences, Inc. and Oct 30, 2026 for Pfizer Inc.).

Which makes more money, Gilead Sciences, Inc. or Pfizer Inc.?

Pfizer Inc. had more revenue: $62.6 B against $29.4 B for Gilead Sciences, Inc., both in the year to December 2025. Gilead Sciences, Inc. earned more: net income of $8.5 B against $7.8 B for Pfizer Inc.

Which is more profitable, Gilead Sciences, Inc. or Pfizer Inc.?

Gilead Sciences, Inc. keeps more of each dollar of sales: a net margin of 28.9% against 12.4% for Pfizer Inc.

Which has more employees, Gilead Sciences, Inc. or Pfizer Inc.?

Pfizer Inc. employs more people: 75,000 against 17,000 at Gilead Sciences, Inc. Each employee brings in about $1,731,941 of revenue at Gilead Sciences, Inc. and $834,387 at Pfizer Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.